📊 ACHC Key Takeaways
Is Acadia Healthcare Company, Inc. (ACHC) a Good Investment?
Despite extraordinary 2485.6% YoY revenue growth, Acadia's fundamentals are deteriorating. Interest coverage of 0.4x indicates the company cannot service debt from operations, negative free cash flow of -$15M shows cash burn, and paper-thin 0.5% net margins suggest the revenue growth came from low-margin acquisitions that are diluting profitability. The combination of high leverage (1.29x debt/equity) with operationally insufficient cash generation creates significant financial stress.
The fundamentals point to a business with severely impaired profitability, as shown by deeply negative operating and net margins, negative returns on assets and equity, and sharply negative EPS. While liquidity is still adequate and operating cash flow remains positive, the combination of heavy capital spending, negative free cash flow, and substantial debt makes the current growth profile low quality and financially risky.
Acadia Healthcare Company, Inc. Key Strengths (ACHC)
- Strong top-line revenue growth of 2485.6% YoY suggests significant scale expansion
- Adequate short-term liquidity with current ratio of 1.71x and $158.5M cash on hand
- Positive operating cash flow of $61.5M provides some debt service capacity
- Revenue scale is large at $3.31B, indicating meaningful market presence
- Current and quick ratios above 1.5x suggest near-term liquidity is not the main issue
- Operating cash flow remains positive at $131.90M despite reported losses
ACHC Stock Risks: Acadia Healthcare Company, Inc. Investment Risks
- Critical interest coverage of 0.4x means operating income cannot cover interest expenses - unsustainable debt burden
- Negative free cash flow of -$15M indicates cash burn despite positive operating cash flow
- Deteriorating profitability with net margin of only 0.5% and ROE of 0.2% despite massive revenue scale
- High leverage of 1.29x debt/equity combined with $2.5B long-term debt and weak interest coverage creates refinancing risk
- EPS declined 537.4% YoY despite revenue growth, suggesting acquisition-driven growth is value-destructive
- Operating margin of -32.2% and net margin of -33.3% indicate severe profitability deterioration
- Free cash flow of -$439.91M shows cash generation is not covering capital needs
- Long-term debt of $2.50B and interest coverage of -38.5x create significant balance-sheet and servicing risk
Key Metrics to Watch
- Interest coverage ratio - must improve above 1.5x for sustainability
- Free cash flow generation - currently negative and unsustainable
- Operating and net profit margins - need meaningful expansion to justify leverage
- Debt maturity schedule and refinancing risk
- Integration efficiency and cost structure of acquired facilities
- Operating margin and net margin recovery
- Free cash flow trend relative to capital expenditures
Acadia Healthcare Company, Inc. (ACHC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Acadia Healthcare Company, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
ACHC Profit Margin, ROE & Profitability Analysis
ACHC vs Services Sector: How Acadia Healthcare Company, Inc. Compares
How Acadia Healthcare Company, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Acadia Healthcare Company, Inc. Stock Overvalued? ACHC Valuation Analysis 2026
Based on fundamental analysis, Acadia Healthcare Company, Inc. shows some fundamental concerns relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Acadia Healthcare Company, Inc. Balance Sheet: ACHC Debt, Cash & Liquidity
ACHC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Acadia Healthcare Company, Inc.'s revenue has grown significantly by 43% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.24 indicates the company is currently unprofitable.
ACHC Revenue Growth, EPS Growth & YoY Performance
ACHC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $770.5M | $4.1M | $0.05 |
| Q3 2025 | $815.6M | $8.4M | $0.40 |
| Q2 2025 | $796.0M | $8.4M | $0.33 |
| Q1 2025 | $768.1M | $8.4M | $0.09 |
| Q3 2024 | $750.3M | $57.7M | $0.74 |
| Q2 2024 | $731.3M | $57.7M | $0.79 |
| Q1 2024 | $704.3M | $57.7M | $0.72 |
| Q3 2023 | $666.7M | $60.8M | $0.78 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Acadia Healthcare Company, Inc. Dividends, Buybacks & Capital Allocation
ACHC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Acadia Healthcare Company, Inc. (CIK: 0001520697)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ACHC
What is the AI rating for ACHC?
Acadia Healthcare Company, Inc. (ACHC) has a Combined AI Grade of C from Claude (C) and ChatGPT (D) with 86% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ACHC's key strengths?
Claude: Strong top-line revenue growth of 2485.6% YoY suggests significant scale expansion. Adequate short-term liquidity with current ratio of 1.71x and $158.5M cash on hand. ChatGPT: Revenue scale is large at $3.31B, indicating meaningful market presence. Current and quick ratios above 1.5x suggest near-term liquidity is not the main issue.
What are the risks of investing in ACHC?
Claude: Critical interest coverage of 0.4x means operating income cannot cover interest expenses - unsustainable debt burden. Negative free cash flow of -$15M indicates cash burn despite positive operating cash flow. ChatGPT: Operating margin of -32.2% and net margin of -33.3% indicate severe profitability deterioration. Free cash flow of -$439.91M shows cash generation is not covering capital needs.
What is ACHC's revenue and growth?
Acadia Healthcare Company, Inc. reported revenue of $828.8M.
Does ACHC pay dividends?
Acadia Healthcare Company, Inc. does not currently pay dividends.
Where can I find ACHC SEC filings?
Official SEC filings for Acadia Healthcare Company, Inc. (CIK: 0001520697) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ACHC's EPS?
Acadia Healthcare Company, Inc. has a diluted EPS of $0.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is ACHC's fundamental grade?
Based on our AI fundamental analysis in June 2026, Acadia Healthcare Company, Inc. has a C grade with 86% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is ACHC stock overvalued or undervalued?
Valuation metrics for ACHC: ROE of 0.2% (sector avg: 16%), net margin of 0.5% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is ACHC's AI grade for 2026?
Our dual AI analysis gives Acadia Healthcare Company, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ACHC's free cash flow?
Acadia Healthcare Company, Inc.'s operating cash flow is $61.5M, with capital expenditures of $76.6M. FCF margin is -1.8%.
How does ACHC compare to other Services stocks?
Vs Services sector averages: Net margin 0.5% (avg: 10%), ROE 0.2% (avg: 16%), current ratio 1.71 (avg: 1.5).